Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

29 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Building global development strategies for cf therapeutics during a transitional cftr modulator era.
Mayer-Hamblett N, van Koningsbruggen-Rietschel S, Nichols DP, VanDevanter DR, Davies JC, Lee T, Durmowicz AG, Ratjen F, Konstan MW, Pearson K, Bell SC, Clancy JP, Taylor-Cousar JL, De Boeck K, Donaldson SH, Downey DG, Flume PA, Drevinek P, Goss CH, Fajac I, Magaret AS, Quon BS, Singleton SM, VanDalfsen JM, Retsch-Bogart GZ. Mayer-Hamblett N, et al. Among authors: durmowicz ag. J Cyst Fibros. 2020 Sep;19(5):677-687. doi: 10.1016/j.jcf.2020.05.011. Epub 2020 Jun 7. J Cyst Fibros. 2020. PMID: 32522463 Free PMC article. Review.
CFTR modulator theratyping: Current status, gaps and future directions.
Clancy JP, Cotton CU, Donaldson SH, Solomon GM, VanDevanter DR, Boyle MP, Gentzsch M, Nick JA, Illek B, Wallenburg JC, Sorscher EJ, Amaral MD, Beekman JM, Naren AP, Bridges RJ, Thomas PJ, Cutting G, Rowe S, Durmowicz AG, Mense M, Boeck KD, Skach W, Penland C, Joseloff E, Bihler H, Mahoney J, Borowitz D, Tuggle KL. Clancy JP, et al. Among authors: durmowicz ag. J Cyst Fibros. 2019 Jan;18(1):22-34. doi: 10.1016/j.jcf.2018.05.004. Epub 2018 Jun 20. J Cyst Fibros. 2019. PMID: 29934203 Free PMC article. Review.
CF end point commentary.
Durmowicz AG. Durmowicz AG. J Cyst Fibros. 2016 Jul;15(4):424. doi: 10.1016/j.jcf.2016.06.003. Epub 2016 Jun 18. J Cyst Fibros. 2016. PMID: 27324552 Free article. No abstract available.
Cystic fibrosis radiographic biomarkers - Commentary.
Durmowicz AG. Durmowicz AG. J Cyst Fibros. 2017 Mar;16(2):172. doi: 10.1016/j.jcf.2017.01.015. Epub 2017 Feb 2. J Cyst Fibros. 2017. PMID: 28162955 Free article. No abstract available.
Cystic fibrosis biomarker - Commentary.
Durmowicz AG. Durmowicz AG. J Cyst Fibros. 2016 Nov;15(6):712-713. doi: 10.1016/j.jcf.2016.10.010. Epub 2016 Nov 11. J Cyst Fibros. 2016. PMID: 27842897 Free article. No abstract available.
Response.
Durmowicz AG, Witzmann KA, Rosebraugh CJ, Chowdhury BA. Durmowicz AG, et al. Chest. 2013 Oct;144(4):1418-1419. doi: 10.1378/chest.13-1517. Chest. 2013. PMID: 24081359 No abstract available.
The risks and benefits of indacaterol--the FDA's review.
Chowdhury BA, Seymour SM, Michele TM, Durmowicz AG, Liu D, Rosebraugh CJ. Chowdhury BA, et al. Among authors: durmowicz ag. N Engl J Med. 2011 Dec 15;365(24):2247-9. doi: 10.1056/NEJMp1109621. N Engl J Med. 2011. PMID: 22168640 Free article. No abstract available.
29 results